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Abstract 27 
 28 
Neutrophils are key players of the innate immune system, that are involved in coordinating 29 
the initiation, propagation and resolution of inflammation. Accurate neutrophil migration 30 
(chemotaxis) to sites of inflammation in response to gradients of chemoattractants is pivotal 31 
to these roles. Binding of chemoattractants to dedicated G protein coupled receptors initiates 32 
downstream signalling events that promote neutrophil polarisation, a prerequisite for 33 
directional migration.  We provide a brief summary of some of the recent insights into 34 
signalling events and feedback loops that serve to initiate and maintain neutrophil 35 
polarisation. This is followed by a discussion of recent developments in the understanding of 36 
in vivo neutrophil chemotaxis, a process that is frequently referred to as ‘recruitment’ or 37 
‘trafficking’. Here, we summarise neutrophil mobilisation from and homing to the bone 38 
marrow, and briefly discuss the role of glucosaminoglycan-immobilised chemoattractants and 39 
their corresponding receptors in the regulation of neutrophil extravasation and neutrophil 40 
swarming. We furthermore touch on some of the most recent insights into the roles of 41 
atypical chemokine receptors in neutrophil recruitment, and discuss neutrophil reverse 42 
(transendothelial) migration together with potential function(s) in the dissemination and/or 43 
resolution of inflammation.   44 
  45 
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List of abbreviations 46 
ACKR – atypical chemokine receptors  47 
COPD – chronic obstructive pulmonary disease 48 
DAG – diacylglycerol 49 
fMLF – N-formylmethionine-leucyl-phenylalanine 50 
GAG – glycosaminoglycans 51 
GAP – GTPase activating protein 52 
G-CSF – Granulocyte colony stimulating factor 53 
GEF – guanine nucleotides exchange factor 54 
GPCR – G protein coupled receptor 55 
GTPase – Guanosine trisphosphatase 56 
IP3 – inositol trisphosphate 57 
LTB4 – leukotriene B4  58 
MTOC – microtubular organising centre 59 
PI3K – phosphoinositide 3-kinase 60 
PIP3 – phosphatidylinositol-(3,4,5)-trisphosphate 61 
PLC – phospholipase C 62 
PTEN – phosphatase and tensin homologue 63 
RasGRP – Ras guanyl releasing protein 64 
SHIP – SH2-containing inositol phosphatase 65 
 66 
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Introduction 68 
Chemotaxis is defined as directed cell migration in response to a gradient of a chemical 69 
stimulus, with migration occurring towards a chemoattractant, or away from a 70 
chemorepellent. Chemotaxis is critical during embryonic development, where it promotes 71 
morphogenetic movements in response to growth factor receptor-mediated gradient sensing 72 
by directional coordinated, collective cell migration. Examples of collective developmental 73 
chemotaxis include the migration of neural crest cells and the angiogenic sprouting of blood 74 
vessels towards growth factors [1]. In contrast, single cell chemotaxis provides a tightly 75 
controlled mechanism throughout life by which immune cells are recruited, usually in 76 
response to G protein coupled receptor (GPCR) stimulation by chemoattractants.   77 
 78 
Chemotaxis has fascinated scientists for decades. Single cells are more amenable to in vitro 79 
analysis than embryos. Neutrophils, the most abundant circulating leukocytes in man, are 80 
short-lived immune cells of the granulocyte lineage. Neutrophils can produce reactive oxygen 81 
species and degranulate, releasing cytotoxic products. Combined with their ability to 82 
phagocytose and kill ingested microorganisms or to release chromatin-rich extracellular traps, 83 
neutrophils provide a first line of defense against bacterial and fungal infections. They are 84 
also key effectors in the inflammatory response (for general reviews [2, 3]). Neutrophils are 85 
highly motile and migrate as single cells with exquisite speed and directionality in response 86 
to chemotattractant stimulation. Chemotaxis in vivo is essential for many of the neutrophil’s 87 
functions throughout its lifetime.  88 
 89 
Experimental models of neutrophil chemotaxis  90 
The highly motile primary neutrophil is very short-lived and not amenable to culture, 91 
transfection or transduction. Although they chemotax very well, freshly purified human 92 
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neutrophils are therefore not frequently used for chemotaxis experiments. Alternative models 93 
that are not always representative of all facets of neutrophil functions are usually used 94 
instead. Freshly isolated (often bone marrow-derived) neutrophils from mice that carry 95 
genetic alterations of interest are frequently the model of choice. Mice, or indeed zebrafish, 96 
offer in addition the opportunity to investigate neutrophil trafficking in vivo. Alternative more 97 
tractable alternatives to primary neutrophils for the study of single cell chemotaxis in vivo 98 
include cultured cells that can be differentiated to become neutrophil-like (e.g. HL-60), and 99 
the social amoeba Dictyostelium discoideum. Over time, primary neutrophils obtained from 100 
knock-out mouse models, transfected cell lines, and genetically modified D. discoideum 101 
strains in combination with in vitro chemotaxis chambers have helped to decipher many 102 
facets of the molecular regulation of chemotaxis [4]. Aided by increasingly powerful 103 
intravital microscopy, in recent years such in vitro studies and relatively straightforward in 104 
vivo recruitment assays have been supplemented with in situ observations of neutrophil 105 
recruitment. Some of the recent advances in the understanding of the molecular regulation of 106 
neutrophil chemotaxis in vitro and insights into the molecular control of neutrophil 107 
trafficking in vivo are discussed here. 108 
 109 
Chemotaxis as a specialised form of cell migration 110 
In chemotaxis, receptor-mediated chemoattractant gradient sensing promotes cell polarisation 111 
and thereby directional cell migration. General features of cell migration have been reviewed 112 
in depth elsewhere [5, 6].  In vitro cell migration occurs by different modes, depending on 113 
whether the cells are on a two-dimensional substrate or within a three-dimensional matrix. In 114 
the first instance, cells adopt a flattened shape, form integrin-based adhesions to the 115 
substratum, use actin-mediated propulsion led by a lamellipodium at their front, and are 116 
characterised by a trailing end [7]. In the latter case, rather than relying on integrin-based 117 
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adhesions [8], neutrophils migrate in a frequently non-proteolytic, amoeboid fashion and 118 
depend on actin-mediated protrusions and myosin II-mediated contractions to propel 119 
themselves through a three-dimensional matrix [9]. In vivo, integrin-dependent steps involve 120 
the breaching of barriers such as the vessel wall, whereas interstitial migration is thought to 121 
be integrin-independent. ‘Amoeboid’ neutrophil migration in the interstitium involves the 122 
selection of a path of least resistance, with neutrophils probing for gaps that permit passage 123 
of their multilobular nuclei. Interestingly, leukocytes undergoing amoeboid chemotaxis 124 
exhibit a typical microtubular organising centre (MTOC) position behind or, in the case of 125 
the neutrophil, in between nuclear lobes. Amoeboid cell migration contrasts with the much 126 
slower polarised ‘mesenchymal’ cell migration (that is exemplified by fibroblasts), which is 127 
characterised by MTOC and Golgi apparatus polarisation in front of the nucleus [10-12]. An 128 
elegant recent study that employed chemotactic mazes with channels of different sizes 129 
demonstrated that the MTOC is a good indicator of the directional choice (or dominant pole) 130 
of chemotaxing leukocytes [13]. Resting neutrophils are comparatively devoid of 131 
microtubules, with chemoattractant stimulation causing microtubular polymerisation. 132 
Interestingly, neutrophil chemotaxis on two dimensional matrices or elastase-depending 133 
invasion, but not transendothelial migration or crawling on immobilised chemoattractants 134 
was shown to depend upon polymerisation of microtubules [14]. 135 
 136 
Chemoattractant sensing by G protein coupled receptors 137 
Chemoattractants bind G protein coupled cell surface receptors (GPCRs) which usually 138 
signal through Gai/0 containing heterotrimeric G proteins (reviewed in [15]). Although there 139 
is some promiscuity, many chemoattractants have dedicated receptors. Several classes of 140 
chemoattractants are known to act on neutrophils. They comprise lipids [e.g. leukotriene B4 141 
(LTB4)], formylated peptides of bacterial or mitochondrial origin [e.g. N-formylmethionine-142 
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leucyl-phenylalanine (fMLF) which is frequently used in vitro], protein fragments (e.g. C5a 143 
and C3a complement fragments) and classical chemokines, which are classed according to 144 
their conserved cysteine residues into CC and CXC groupings. Table 1 provides a summary 145 
of some major neutrophil chemoattractants together with their receptors. Many chemokines 146 
can bind to extracellular glycosaminoglycans (GAGs) expressed by endothelial cells (or 147 
outside of the vasculature to the extracellular matrix). This serves to essentially immobilise 148 
the gradient, which is important, for example in the context of blood flow [16, 17]. The 149 
directional cell movement on immobilised chemoattractants is sometimes referred to as 150 
‘haptotaxis’. Experiments involving the simultaneous application of several chemoattractants 151 
in vitro established chemoattractants to exist in a hierarchy, with ‘end-target’ attractants (e.g. 152 
fMLP or C5a) overruling intermediary chemoattractants (e.g. LTB4). Unsurprisingly, the 153 
signalling pathways employed by intermediary and end-target chemoattractants are non-154 
identical [18, 19].  155 
 156 
Molecular events regulating neutrophil polarisation.  157 
Chemoattractant-sensing GPCRs are distributed uniformly on the neutrophil’s surface. Both 158 
directional and indeed uniform chemokine receptor stimulation of neutrophils in a dish 159 
causes them to polarise, that is to say, adopt the morphology of the migrating cell described 160 
above, prior to actually migrating in a directional, or random fashion by chemotaxis or 161 
chemokinesis, respectively (Fig 1 for a simplified view of a polarised neutrophil). 162 
   163 
On a molecular level, chemoattractant binding induces the G protein coupled chemoattractant 164 
receptor to undergo a conformational change that allows it to activate heterotrimeric G 165 
proteins, exchanging GDP for GTP on the Ga subunit. This in turn induces the release of the 166 
Gbg subunits, so that both Ga-GTP and Gbg can activate downstream effectors, including 167 
 8 
phospholipase C (PLC) b via Ga and Gbg as well as agonist-activated phosphoinositide 3-168 
kinase (PI3K) by Gbg subunits  [20, 21]. Four agonist-activated PI3Ks are expressed in the 169 
neutrophil, PI3Ka, PI3Kb, PI3Kd and PI3Kg [22]. Of these, PI3Kg is activated directly by 170 
Gbg in concert with Ras-GTP [23], with Ras being activated downstream of PLCb by 171 
RasGRP4 [24]. Both PLCs and agonist activated PI3Ks are well known regulators of 172 
phosphoinositides, lipid components of cellular membranes, with PLCs catalysing plasma 173 
membrane phosphatidylinositol(4,5)bisphosphate [PI(4,5)P2] hydrolysis to generate inositol 174 
trisphosphate (IP3) and diacylglycerol (DAG), whereas PI3Ks phosphorylate PI(4,5)P2 in the 175 
3’ position, generating the lipid second messenger phosphatidylinositol(3,4,5)trisphosphate 176 
(PIP3). Several PI3K isoforms are thought to be involved in chemotaxis, likely at least in part 177 
because the individual PI3K isoforms cross-talk extensively [25]. The PI3K pathway 178 
provides the mechanistic backdrop to the well-documented PIP3 polarisation to the leading 179 
edge of polarised neutrophils, neutrophil-like cells and dictyostelium [26-28]. Many PI3K 180 
effectors are regulators of small GTPases, in particular guanine nucleotide exchange factors 181 
(GEFs) and GTPase activating proteins (GAPs). These PIP3-responsive regulators of small 182 
GTPases in polarised neutrophils together promote actin-dependent protrusion, for example 183 
by activating Rac1/2 and Arf6 and inactivating RhoA at the cell’s pseudopod (reviewed in 184 
[29, 30]). Research by many groups into the function of PI3K/PIP3, and into individual PI3K 185 
isoforms in chemotaxis resulted in somewhat contradictory reports. Taken together, this large 186 
body of work suggests that individual PI3K isoforms, in particular PI3Kg/d, regulate 187 
chemokinesis and/or chemotaxis in an assay-, substratum- and in the case of human 188 
neutrophils likely also priming-dependent fashion [31-38]. D. discoideum cells were shown 189 
to be able to chemotax poorly even in the absence of any PI3K isoform [39]. Human 190 
neutrophils from chronic obstructive pulmonary disease (COPD) patients and the elderly 191 
were characterised by excessive PI3K activity and poor chemotactic directionality, and could 192 
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be rescued with low concentrations of inhibitors of the leukocyte-specific PI3Kg/d that 193 
partially inhibited these enzymes [40, 41]. This suggests that a ‘goldilocks principle’ applies 194 
in chemotaxis, whereby too much PI3K activity may be just as disruptive as too little.  195 
 196 
Neutrophil polarisation involves players including the above discussed PI3Ks and their 197 
effectors, as well as PIP3 phosphatases. Amongst the numerous phosphoinositide 198 
phosphatases that are expressed by leukocytes, the 3’ phosphatase PTEN and the 5’ 199 
phosphatase SHIP are best understood; both were shown to regulate chemotaxis [18, 26, 42]. 200 
PTEN-mediated regulation was found to be rather context-dependent, with it being suggested 201 
to control chemotaxis in the presence of two opposing gradients, and in distinguishing 202 
between end-point and intermediate point chemoattractants [18]. In contrast, SHIP-deficient 203 
neutrophils were extremely spread and failed to polarise or chemotax effectively [26, 42]. 204 
Further important contributions are likely regulated by feed-back loops. For instance, Rho 205 
GTPases, actin polymerisation and PIP3 polarisation at the cell’s front act in one such feed-206 
back loop [43-46]. Likely driven by PIP3-dependent Rac GEFs such as P-Rex1/2 and 207 
DOCK2 [29], Rac activation has been shown to maintain neutrophil polarity through Hem-1, 208 
which assists in polarising the neutrophil by facilitating actin polymerisation and excluding 209 
myosin activity at the front of the cells, whilst also promoting Rac activity at the front in a 210 
positive feedback loop [47]. The RhoA and Arf6 GAP ARAP3 is being recruited to the 211 
plasma membrane in a PIP3 dependent fashion, regulating persistent PIP3 polarisation and 212 
chemotactic directionality [48].  213 
 214 
In the presence of uniform chemoattractant, neutrophils polarise randomly. Membrane 215 
tension is one factor that has been shown to be involved in the regulation of such neutrophil 216 
polarisation. Leading edge protrusions generate strong membrane tensions, thus inhibiting the 217 
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formation of secondary protrusions elsewhere in the neutrophil, and maintaining persistent 218 
polarisation [49]. In neutrophils that make contact with the substratum, a further regulatory 219 
input stems from altered membrane curvature. This is thought to be sufficient to break the 220 
symmetry of the non-polarised neutrophil, establishing cytoskeletal back polarisation in the 221 
adhering neutrophil in a PI4P, SRGAP2 and PIP5K1C90-dependent fashion [50]. 222 
 223 
In vivo neutrophil chemotaxis (trafficking) 224 
Neutrophils migrate to new locations at least twice, and potentially more during their short 225 
lives. All neutrophil trafficking events have their regulation by chemoattractant-mediated 226 
chemotaxis in common. The remaining part of this minireview summarises some of the 227 
recent insights into in vivo neutrophil chemotaxis in a range of situations (see Fig 2 for a 228 
schematic diagram). 229 
 230 
Neutrophil chemotaxis during mobilisation and homing 231 
Neutrophil differentiation from progenitors occurs in the bone marrow, with 107 and 1011 232 
neutrophils released into the circulation each day in mouse and human, respectively. The 233 
regulation of neutrophil release into the circulation has been elucidated with the help of 234 
genetically modified mice. Immature and mature neutrophils are retained in the bone marrow 235 
by CXCR4 chemokine receptor expression that is responsive to CXCL12 produced by bone 236 
marrow stromal cells. The major mobilising cytokine G-CSF causes downregulation of 237 
CXCR4 on neutrophils and of CXCL12 in the bone marrow [51], as well as upregulation of 238 
CXCR2. With the CXCR2 agonists CXCL1 and CXCL2 constitutively expressed by bone 239 
marrow endothelium, these changes drive neutrophil mobilisation from the bone marrow to 240 
the circulation [52].  241 
 242 
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Circulating neutrophils under homeostatic conditions are short-lived, persisting in the 243 
circulation for only one day before becoming senescent. Senescent neutrophils upregulate 244 
CXCR4, which increases their sensitivity to CXCL12 that is expressed in the bone marrow. 245 
In this way, senescent neutrophils are recruited or ‘home’ back to the bone marrow, where 246 
they undergo apoptosis for clearance by stromal macrophages [53, 54]. Interestingly, both 247 
neutrophil release into the circulation and clearance of senescent neutrophils occur in a 248 
circadian rhythm, providing immunity while protecting the host [55, 56]. 249 
  250 
Neutrophil recruitment to inflammatory sites – extravasation  251 
As the first circulating immune cells to be recruited to sites of inflammation, neutrophils 252 
present a first line of cellular defense against infections. The initial step of neutrophil 253 
recruitment from the circulation into the inflamed tissue is best understood in the inflamed 254 
cremaster muscle, a site that is particularly amenable to intravital microscopy. Initially, 255 
circulating, non-adhesive neutrophils form L-selectin and b2 integrin-mediated interactions 256 
on the luminal face of the wall of post-capillary venules [reviewed in [57]]. This is induced 257 
by cytokine production (e.g. TNF) by resident macrophages, which in turn causes 258 
upregulation of adhesion molecules (P- and E-selectins and integrin ligands including 259 
ICAM1) as well as chemokines by the endothelium. Selectin-mediated interactions cause 260 
neutrophil rolling along the endothelium, allowing neutrophil interactions with chemokines to 261 
take place. Additional chemokine stimulation drives integrin activation and in turn integrin-262 
mediated neutrophil adhesion to the endothelial surface. Immobilisation of the chemokines to 263 
the luminal face of the endothelium occurs due to CXCL1/CXCL2/CXCL8 binding to GAGs, 264 
carbohydrate moieties that are expressed on the endothelial cell surface. In some 265 
circumstances, GAGs not only bind, but transcytose chemokines [16, 17, 58]. GAG 266 
chemokine immobilisation efficiency is chemokine-dependent, with chemokine 267 
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immobilisation avoiding chemokine diffusion despite the blood flow in the vessel. In this 268 
way, GAG-dependent chemokine presentation ensures that rolling, but not circulating 269 
neutrophils are activated while at the same time directing neutrophils to extravasate at 270 
specific sites [59].  271 
 272 
Neutrophil swarming  273 
Neutrophil-mediated amplification of a chemotactic gradient by neutrophil-mediated release 274 
of ‘intermediate-target’ chemoattractants (such as the lipid mediator LTB4, which was to be 275 
found stored in exosomes) can be induced by ‘end target’ chemoattractants such as C5a, 276 
bacterial formylated peptides, and cell death, which leads to the release of formylated 277 
mitochondrial proteins [60, 61]. This autocrine-paracrine chemoattractant signal 278 
amplification loop causes directional collective neutrophil recruitment (‘swarming’) in 279 
response to the activation of a leading neutrophil (Fig 2). By generating LTB4, the leading 280 
neutrophil instigates BLT1-mediated activation of the following neutrophils, which in turn 281 
generate more LTB4 [62, 63]. Interestingly, microlesions, such as those caused by the death 282 
of individual parenchymal cells have recently been shown to be shielded by resident 283 
macrophages. This neatly avoids a neutrophil swarming response to the released formylated 284 
peptide and concomitant bystander host injury caused by neutrophil-derived inflammation 285 
[64]. 286 
 287 
Neutrophil recruitment to inflamed sites by series of chemoattractants 288 
In recent years it has come to be recognised that neutrophil recruitment to sites of 289 
inflammation in vivo is regulated by a hierarchical series of chemoattractants. This principle 290 
has been shown to hold true in several in models of sterile inflammation and injury. It is 291 
illustrated for example by neutrophil recruitment to the inflamed joint of mice in the K/BxN 292 
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serum transfer model of rheumatoid arthritis. A series of elegant studies performed over a 293 
number of years that combined mouse genetics and lately multiphoton intravital signalling 294 
elucidated the sequential action of neutrophil chemoattractants in this disease model. Hence, 295 
the deposition of immune complexes on the surface of the joint triggers the alternative 296 
complement pathway, precipitating C5a generation and subsequent C5a deposition on the 297 
luminal surface of the joint vasculature, where it is immobilised in a GAG-mediated fashion. 298 
C5a binding to its receptor C5aR1 promotes b2 integrin activation, causing neutrophils to 299 
arrest, spread and crawl on the joint endothelium. C5a also causes neutrophil-driven 300 
amplification of the chemotactic gradient by releasing LTB4, and in turn promoting BLT1-301 
mediated extravasation into the joint tissue by autocrine-paracrine positive feedback loop. 302 
Here, immune complex-mediated FcgR stimulation causes neutrophils to release IL-1b. This 303 
in turn induces the generation of endothelial cell- and synovial fibroblast-derived CCR1 and 304 
CXCR2 chemokine receptors ligands. CCR1 promotes neutrophil crawling on the joint 305 
endothelium with neutrophil-generated CXCL2 orchestrating CXCR2-dependent 306 
amplification of neutrophil recruitment to the joint [65-68].  307 
 308 
Optimisation of neutrophil directional migration by atypical chemokine receptors 309 
In addition to G protein coupled chemokine receptors with signalling function, leukocytes 310 
and stromal cells also express atypical chemokine receptors (ACKRs; table 1; Fig 2), which 311 
do not signal through heterotrimeric G proteins. ACKRs are also known as scavenger or 312 
decoy receptors, since some internalise and degrade chemokines, essentially functioning as 313 
sinks to limit excessive inflammation [69, 70]. For example, ACKR2 was shown to limit 314 
inflammation by reducing neutrophil directional migration to inflammatory chemokines by 315 
competing for CCR1 ligands in a neutrophil autonomous fashion  [71].  316 
 317 
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Neutrophil non-autonomous mechanisms also employ decoy receptors to finely tune 318 
neutrophil migration. Unlike other atypical chemokine receptors, ACKR1 optimises 319 
leukocyte extravasation by internalising and transcytosing chemokines [72, 73]. Some of the 320 
latest studies in this area have coupled high resolution intravital imaging with genetics to 321 
demonstrate how atypical chemokine receptors optimise neutrophil recruitment to inflamed 322 
sites. Two atypical chemokine receptors were shown to jointly regulate neutrophil 323 
recruitment to the inflamed joint in K/BxN serum transfer arthritis. Hence, C5aR2, an 324 
atypical C5aR expressed by endothelial cells transports tissue-derived C5a across the 325 
endothelium to be exposed on the luminal side, in this way aiding with arresting C5aR1-326 
expressing neutrophils. At the same time, endothelial ACKR1 was shown to transport 327 
synovial tissue-derived CXCR2 ligands across the joint endothelium, facilitating neutrophil 328 
adhesion and extravasation [74]. 329 
 330 
A separate study identified how the two CXCR2 ligands, CXCL1 and CXCL2 sequentially 331 
direct neutrophil extravasation in the inflamed cremaster muscle. In this instance endothelial 332 
and pericyte GAG-immobilised CXCL1 promoted neutrophil adhesion and crawling, whereas 333 
CXCL2 controlled transendothelial migration. Fascinatingly, the source of CXCL1 was 334 
endothelial cells and pericytes, whereas CXCL2 was generated and released by neutrophils in 335 
another example of a paracrine amplification loop of directional neutrophil migration. 336 
Neutrophil-derived CXCL2 was subsequently immobilised by ACKR1 expressed by 337 
pericytes at venular cell-cell junctions, supporting the correct directionality of neutrophil 338 
transendothelial migration [75].   339 
 340 
Reverse Migration  341 
 15 
To avoid excessive inflammation, neutrophils were long thought to undergo apoptosis, 342 
followed by being cleared (‘efferocytosed’) by resident pro-resolution macrophages at sites 343 
of inflammation [76]. Recent observations have, however, suggested that this may not be the 344 
only possible fate of the neutrophil in sterile inflammation. Rather than undergoing apoptosis 345 
and dying, neutrophils were found to migrate away from a sterile wound in zebrafish larvae, 346 
including, on occasion, entering the vasculature [77]. Zebrafish neutrophils express two 347 
chemokine receptors, CXCR1 and CXCR2, of which CXCR1 regulates recruitment to the 348 
sterile wound, and CXCR2 promotes CXCL8-induced reverse migration, which interestingly 349 
occurred by chemokinesis rather than chemotaxis [78], a view shared by a separate study 350 
[79]. Interestingly, reverse migration may promote wound healing, since wounds in zebrafish 351 
that are genetically deficient in CXCR2/CXCL8 displayed heightened inflammation [78]. 352 
This view is supported by other observations made in the zebrafish, where retaining zebrafish 353 
neutrophils at the wound site and reducing neutrophil apoptosis by inducing HIF1a was also 354 
pro-inflammatory [80]. In a similar vein, tashinone IIA, an active compound from a Chinese 355 
medicinal herb, that promoted neutrophil reverse migration was isolated in a zebrafish screen 356 
aimed at identifying compounds that would aid the resolution of inflammation [81]. 357 
Interestingly, unlike their mammalian counterparts, neutrophils in zebrafish larvae are 358 
generally tissue resident [82]. Therefore, the term reverse migration refers merely to the 359 
direction of migration in the zebrafish, whilst it generally includes the breaching of the vessel 360 
wall in the luminal direction (i.e. reverse transendothelial migration) in mammals. Reverse 361 
migration has been suggested to occur, too, in humans. This view is controversial, however, 362 
with circulating neutrophils that comprise a ‘reverse migration signature’ (CD54hi CXCR1low) 363 
being 4-8x more abundant in patients with systemic inflammation than in healthy individuals 364 
[83]. Yet, there is evidence to support a potential role of neutrophil reverse migration in the 365 
dissemination of inflammation from mouse models, where reverse migrated mouse 366 
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neutrophils observed after ischemia reperfusion injury augmented instances of inflammation 367 
in the lung [84]. A subsequent study identified following ischemia reperfusion injury that 368 
neutrophil-derived LTB4 and elastase were responsible for loss of junctional JAM-C, 369 
permitting neutrophil reverse (transendothelial) migration, with reverse migrated neutrophils 370 
again travelling to the lung to spread inflammation [85]. In a separate study the neutrophilic 371 
response to a small localised burn in the liver was observed by intravital microscopy. This 372 
induced neutrophil recruitment to the injury site, where neutrophils aided tissue repair, 373 
phagocytosing dead tissue. Rather than undergoing apoptosis for phagocytosis at the injury 374 
site, neutrophils once more left the wound, employing proteases to re-enter the vasculature by 375 
reverse transendothelial migration. They entered the lung, and upregulated CXCR4 prior to 376 
homing to the bone marrow for non-inflammatory clearance [86]. Clearly neutrophil reverse 377 
migration is a very interesting area which remains to be further investigated and fully 378 
understood. Does reverse migration only occur in response to sterile injury and, conversely, 379 
is apoptosis at the site of inflammation followed by efferocytosis more typical of neutrophils 380 
at sites of infection? Could reverse migration be involved in inducing lung injury under 381 
certain but not all instances? It will be exciting to follow new developments in this area in the 382 
future.  383 
 384 
Conclusion 385 
This minireview has highlighted key points of neutrophil chemotaxis, focussing on some 386 
molecular events that were shown in vitro to regulate neutrophil polarisation and 387 
summarising some exciting developments in neutrophil trafficking in vivo. The mind-388 
boggling complexity of the regulation of neutrophil chemotaxis is fascinating to the basic 389 
scientist and provides evidence of the physiological importance of the process that is being 390 
regulated. Meticulous regulation of neutrophil chemotaxis is required to balance neutrophilic 391 
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inflammation, to ensure adequate host defense while avoiding excessive host damage. As 392 
evidenced by rare genetic diseases such as leukocyte adhesion deficiencies, in which b2 393 
integrins are absent or their signalling dysfunctional, interfering with leukocyte recruitment 394 
leaves the body open to recurrent serious bacterial infections. Conversely, certain chronic 395 
inflammatory diseases (e.g. rheumatoid arthritis or chronic obstructive pulmonary disease) 396 
are characterised by excessive neutrophilic inflammation.  Therapeutically targeting 397 
neutrophil chemotaxis to alleviate such conditions may be feasible, but could result in 398 
reduced host immunity as a trade-off.  399 
  400 
 18 
Summary Points 401 
• Chemotaxis is defined as directional cell migration towards a source of chemoattractant, 402 
whilst chemokinesis is chemoattractant-induced cell migration in the absence of a gradient.  403 
• Chemotaxis bears all the hallmarks of random migration, but in addition is characterised by 404 
chemoattractant-induced polarisation, and directionality towards a source of chemoattractant  405 
• Chemoattractants include lipids, peptides, protein fragments and chemotactic cytokines 406 
(chemokines). They are classed into intermediary and end-point chemoattractants, and 407 
operate in a hierarchical fashion. Chemoattractants signal through G protein coupled 408 
receptors. Atypical chemoattractant receptors bind chemoattractant without inducing 409 
intracellular signalling. 410 
• Being amongst the fastest chemotaxing cells in the human body, neutrophils provide a first 411 
line of defense against infections.  412 
• Leukocyte recruitment to a site of inflammation is directed by chemoattractants and 413 
therefore corresponds to chemotaxis in vivo. This area has been revolutionised by genetic 414 
approaches in combination with intravital imaging. Many of the latest insights are concerned 415 
with the integration of different chemoattractants by the migrating cell, paracrine 416 
amplification loops (‘swarming’) and reverse migration (ie away from the source of 417 
chemoattractant).  418 
 419 
 420 
 421 
 422 
 423 
 424 
  425 
 19 
 Receptor Chemoattractant Alternative name Function 
Chemokine Receptors CXCR2 CXCL1 Gro-a (human) 
KC (mouse)* 
Neutrophil recruitment & 
activation  
 CXCR2 CXCL2 Gro-b (human) 
MIP2 (mouse)* 
Neutrophil trafficking 
 CXCR1 CXCL8 Interleukin 8 (IL-8)* Neutrophil recruitment to 
sites of inflammation 
 CXCR4 CXCL12 Stromal cell derived factor 
1 (SDF1) 
Bone marrow homing  
Chemoattractant 
Receptors  
BLT1 LTB4 
(leukotriene B4) 
 Neutrophil recruitment 
and swarming  
 FPR1 
(also known as fMLPR) 
FPR2 
Bacterial and 
mitochondrial formylated 
peptides, e.g. fMLF 
 Neutrophil recruitment  
 C5aR C5a  Neutrophil recruitment (eg 
in autoantibody induced 
disease) 
 C3aR C3a  Inhibitor of neutrophil 
mobilisation  
Atypical Chemokine 
receptors 
ACKR1 
(formerly Duffy antigen 
receptor) 
  Chemokine transcytosis; 
Haematopoiesis and 
neutrophil blood counts 
[87] 
 ACKR2  
(formerly D6) 
Inflammatory CC 
chemokines 
 Decoy / scavenger 
receptor  
 
Michael and Vermeren, Table 1. 
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Figure and Table Legends.  
Table 1. Common neutrophil chemoattractants and their receptors. In addition to 
chemotactic cytokines (chemokines), which bind to chemokine receptors that signal or 
atypical chemokine receptors that do not signal, neutrophils express a series of 
chemoattractant receptors, which bind to lipids, peptide, protein fragments or chemokines. In 
additional to atypical chemokine receptors (ACKRs), there are also atypical chemoattractant 
receptors, e.g. C5aR2, see main text. * Note, CXCL8/IL-8 and its receptor CXCR1 are lost in 
the mouse, where CXCL1/KC and CXCL2/MIP2 and their receptor CXCR2 appear to act as 
functional homologues. 
 
Figure 1. Molecular signalling events in neutrophil polarisation allowing movement 
towards the chemotactic gradient. Binding of a chemoattractant to the G-protein coupled 
chemoattractant receptor induces intracellular signalling to regulate neutrophil polarisation. 
Polarised neutrophils are characterised by accumulation of PIP3 to the leading edge, where 
effectors such as Rho GEFs and GAPs promote actin polymerisation. Polarisation is 
maintained by feedback loops, for example inhibiting RhoA at the pseudopod. The bulky 
nucleus is used as a ‘mechanical gauge’ that together with the MTOC facilitates the cell’s 
progress through pores in the interstitium. Trailing end retraction is facilitated by microtubule 
depolymerisation, activating RhoA and triggering actomyosin contractility in addition to 
feedback loops involving RhoA, Rac and PTEN.  
 
Figure 2.  Neutrophils are controlled by chemotaxis. Clockwise, from top left: 
Mobilisation and Homing. CXCR2 signalling leads to the mobilisation of neutrophils from 
the bone marrow into the bloodstream, whereas upregulation of CXCR4 in senescent 
neutrophils promotes chemokine-driven homing back to the bone marrow. Recruitment. 
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Resident macrophages at inflammatory sites release pro-inflammatory mediators that 
promote selectin-mediated interactions between neutrophils and the endothelium. Neutrophils 
tether and roll along the endothelium, where GAG-immobilised chemokines guide the 
neutrophils through G protein coupled receptor signalling, regulating integrin-mediated 
neutrophil extravasation. Atypical chemokine receptors have been shown to aid neutrophil 
recruitment to sites of inflammation. Swarming. Certain end-target chemoattractants cause 
the release of LTB4 containing exosomes. An autocrine-paracrine feedback amplification 
loop promotes directional migration of many neutrophils in a ‘swarm’. Chemoattractant 
hierarchies. In vivo the neutrophil encounters multiple chemoattractants, the response to 
which must be tightly regulated. For example, neutrophils choose ‘end-target’ 
chemoattractants over intermediate chemoattractants. Reverse migration. Neutrophil reverse 
(transendothelial) migration has been observed in many contexts and, perhaps depending on 
circumstances, may or may not have pro-inflammatory consequences. See text for further 
discussion. 
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